Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children

Journal: European Journal of Internal Medicine
Lead Author: Conte et al.
Original date of publication: 09/01/2023
Link: https://pubmed.ncbi.nlm.nih.gov/37311686/

Summary Context

Moderna recipients in Italy were 6 times more likely to develope myocarditis during the high risk period (28 days after shot)

Comments

This study noted that people younger than 30 at most risk after vaccination for pericarditis.

Abstract or Results, Key Passages

“we may speculate that mRNA SARS-CoV-2 vaccines, like other vaccines, act as a non-specific trigger that in a limited number of susceptible subjects may activate the inflammatory pathways inducing myocarditis and pericarditis.” “The main results of the present study are: 1) a higher risk of both myocarditis and pericarditis was recorded during the first 28 days after mRNA SARS-CoV-2 vaccine dose (both Moderna and Pfizer vaccine)”

Keywords: adverse events Cardiac events covid vaccine mRNA myocarditis

Full Author List: Edoardo Conte, Olivia Leoni, Enrico Ammirati, Massimo Imazio, Antonio Brucato

Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children

Summary Context

Comments

Abstract or Results, Key Passages

Previous PostMyocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Next PostEpidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada